Hypokalemic periodic paralysis associated with hypophosphatemia in a patient with hyperinsulinemia

American Journal of the Medical Sciences

Volumn 318, Issue 1, 1999, Pages 69-72

  Ogawa, Touru ^a   Kamikubo, Keita ^b  

^a Takayama Red Cross Hospital   (Japan)

^b Kamikubo Medical Clinic   (Japan)

Author keywords

Hyperinsulinemia; Hypokalemia; Hypophosphatemia; Periodic paralysis

Indexed keywords

INSULIN; PHOSPHATE; POTASSIUM;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROLYTE DISTURBANCE; HUMAN; HYPERINSULINEMIA; HYPOKALEMIC PERIODIC PARALYSIS; HYPOPHOSPHATEMIA; MALE; ORAL GLUCOSE TOLERANCE TEST; POTASSIUM TRANSPORT;

EID: 0033499256     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40576-2     Document Type: Article

References (29)

1. Riggs JE. Periodic paralysis. Clin Neuropharmacol 1989;12: 249-57.
2. Shy GM, Wanko T, Rowley PT, et al. . Studies in familial periodic paralysis. Exp Neurol 1961;3:53-7.
3. Layzer RB. Periodic paralysis and the sodium potassium pump. Ann Neurol 1982;11:547-52.
4. Allot EN, McArdle B. Further observations on familial periodic paralysis. Clin Sci 1938;3:229-33.
5. Talbott JH. Periodic paralysis, a clinical syndrome. Medicine (Baltimore) 1941;20:85-92.
6. Bienert HJ Jr, Weaver CD. Thyrotoxicosis presenting as hypokalemic periodic paralysis. South Med J 1968;61:189-92.
7. Guthrie GP Jr, Curtis J, Beilman KM. Hypophosphatemia in thyrotoxic periodic paralysis. Arch Intern Med 1978;138:1284-5.
8. Lerner E, Wachtel TJ. Thyrotoxic periodic paralysis: case discussion and review. R I Med J 1985;68:219-22.
9. Tinker TD, Vannatta JB. Thyrotoxic hypokalemic periodic paralysis: report of four cases and review of the literature. J Okla State Med Assoc 1987;80:11-5.
10. Nora N, Berns A. Hypokalemic, hypophosphatemic thyrotoxic periodic paralysis. Am J Kidney Dis 1989;13:247-9.
11. Woolery WA, Gharib H. Thyrotoxic hypokalemic periodic paralysis in a white man. South Med J 1991;84:1399-1401.
12. Delage R, Lebel M. Potential role of acute hypophosphatemia during hypokalemic periodic paralysis attack. Med Hypothesis 1990;32:273-5.
13. Norris KC, Levine B, Ganesan K. Thyrotoxic periodic paralysis associated with hypokalemia and hypophosphatemia. Am J Kidney Dis 1997;28:270-3.
14. Kusakabe T, Yoshida M, Nishikawa M. Thyrotoxic periodic paralysis: a peculiar case with unusual dystonic behavior and variable relations of paralysis to serum potassium levels. J Clin Endocrinol Metab 1976;43:730-41.
15. Jurkat-Rott K, Lehmann-Horn F, Elbaz A, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 1994;3:1415-9.
16. Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 Caucasian families. Am J Hum Genet 1995;56:374-80.
17. Ptacek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 1994;77:863-8.
18. Plassart E, Elbaz A, Santos JV, et al. Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP). Hum Genet 1994;94:551-6.
19. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine (Baltimore) 1992;71:109-20.
20. Ferreiro JE, Arguelles DJ, Rams H Jr Thyrotoxic periodic paralysis. Am J Med 1996;80:146-50.
21. Riley MS, Schade DS, Eaton RP. Effects of insulin infusion on plasma phosphate in diabetic patients. Metabolism 1979;28:191-4.
22. Moore RD. Effects of insulin upon ion transport. Biochim Biophys Acta 1983;737:1-49.
23. Taylor DJ, Coppack SW, Cadoux-Hudson TAD, et al. Effect of insulin on intracellular pH and phosphate metabolism in human skeletal muscle in vivo. Clin Sci 1991;81: 123-8.
24. Polgreen KE, Kemp GJ, Leighton B, et al. Modulation of Pi transport in skeletal muscle by insulin and IGF-1. Biochim Biophys Acta 1994;1223:279-84.
25. Kemp GJ, Land JM, Coppack SW, et al. Skeletal muscle phosphate uptake during euglycemic-hyperinsulinemic clamp. Clin Chem 1993;39:170-1.
26. Cohen P, Barzilai N, Lerman A, et al. Insulin effects on glucose and potassium metabolism in vivo: evidence for selective insulin resistance in humans. J Clin Endocrinol Metab 1991;73:564-8.
27. Sestoft L. Metabolic aspects of the calorigenic effect of thyroid hormone in mammals. Clin Endocrinol 1980;13:489-506.
28. Body JJ, Cryer PE, Offord KP, et al. Epinephrine is a hypophosphatemic hormone in man. Physiologic effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone and calcitonin. J Clin Invest 1983;71:572-8.
29. Kjeldsen SE, Os I, Westheim A, et al. Decreased serum phosphate in essential hypertension related to increased sympathetic tone. Am J Hypertens 1988;1:403-9.